naltrexone
immune therapeutics,statera biopharmaceuticals
['naltrexone']
i have had multiple patients who recently reported substantial benefit from low dose naltrexone very interesting study that is currently assessing it - primary outcome is a pro! super curious to see results #acr22 #acrambassador #vasculitis22 
MCW Rheumatologist | Internal Medicine APD | Rheumatology APD | Med Dir Vasculitis Program | Host, EBRheum Podcast | https://t.co/o4nOnziCiM | Newsletter: